Skip to content

Mayfield Brain & Spinal Column

Official Blog of Mayfield Brain & Spine

  • MayfieldClinic.com
  • Contact us

Category: Brain Tumors

Dr. Warnick 5000 radiosurgeries

Dr. Warnick reaches milestone of 5,000 radiosurgeries

April 1, 2025 Cliff Peale Brain Tumors, Gamma Knife, Research, Trigeminal Neuralgia

Dr. Ronald Warnick has completed the 5,000th radiosurgery of his distinguished career. Through groundbreaking advances in research, technology and technique, he has helped make radiosurgery safer, more effective and more widely available.

Read more

Mayfield-led research will guide physicians, benefit patients

February 11, 2025 Cliff Peale Brain Tumors, Complex Spinal Deformity, Gamma Knife, Research, skull base, Spine Care, Trigeminal Neuralgia

Research that helps physicians effectively treat a wide variety of neurosurgical disorders – ranging from brain tumors to spinal deformity to severe facial pain – was a focus of Mayfield Brain &

Read more

Mayfield CEO: At 85, Mayfield continues to grow and serve

June 30, 2022 Cliff Peale Brain Tumors, Community, Physical Therapy, Spine Care, Stroke

Mark Vorherr, Mayfield’s chief executive officer, provided a few thoughts as Mayfield approaches its 85th anniversary. Cincinnatians know the name “Mayfield.”

Read more

Studies on Gamma Knife radiosurgery earn recognition

January 24, 2022 Cliff Peale Brain Tumors, Gamma Knife

How can Gamma Knife radiosurgery help patients with various types of brain tumors and blood vessel abnormalities? Four studies from Dr. Ronald Warnick and co-authors from IRRF.

Read more

Self-analysis at Gamma Knife Center promotes safety, reliability

October 20, 2021 Cliff Peale Brain Tumors

By Dr. Ronald Warnick Gamma Knife radiosurgery is well established as a targeted treatment for brain tumor patients, using 192 beams of radiation that intersect at a single point with an accuracy

Read more
GammaTile Therapy

Mayfield listed among elite brain tumor specialists

February 2, 2021 Cliff Peale Brain Tumors

Mayfield continues to expand its use of the groundbreaking GammaTile® targeted radiation technology to treat brain tumors, putting it among a distinguished roster of national health systems. In recent months, Mayfield neurosurgeons

Read more

When to get a second opinion: a Q&A with Dr. Chris McPherson

February 10, 2020 Cliff Peale Brain Aneurysm, Brain Tumors, Chiari, Chronic Pain, Complex Spinal Deformity, PM&R, skull base, Spine Care, Stroke, Trigeminal Neuralgia

You are hardly alone if a significant medical diagnosis has stopped you in your tracks and caused you to wonder whether you should get a second opinion. Christopher McPherson, MD, a neurosurgeon

Read more

Working in a danger zone: Treating cavernous sinus meningiomas effectively & safely

June 3, 2019 Cliff Peale Brain Tumors, skull base

By Yair Gozal, MD, PhD Cavernous sinus meningiomas – benign yet threatening tumors – are lodged in a most inconvenient location. They sit above the skull at the base of the brain,

Read more

Mayfield lifts brain tumor programs in 3 health systems

May 15, 2019 Cliff Peale Brain Tumors, skull base

Brain Tumor Awareness Month is a perfect time to reflect on the role of Mayfield Brain & Spine as a catalyst for excellence in three major health systems in the Cincinnati-Northern Kentucky

Read more

Awake craniotomy: when patients play a role in their own brain surgery

November 27, 2018 Cliff Peale Brain Tumors

By Christopher McPherson, MD It sounds like something out of a Hollywood movie: having brain surgery while you’re awake! In fact, it is painless. More importantly, it can save your life.

Read more

Cesium implants: a highly targeted option for some brain tumors

November 9, 2018 Cliff Peale Brain Tumors

By Christopher McPherson, MD When the diagnosis is a brain tumor, we need to consider all the options. The big four comprise surgery, radiation, chemotherapy, and immunotherapy. A lesser-known treatment that can

Read more

An aggressive brain tumor comes into molecular focus

September 25, 2018 Cliff Peale Brain Tumors, Research

Fifty years ago the median survival for an individual diagnosed with glioblastoma multiforme, the aggressive brain cancer, was 7 months. Today it is 15 months.

Read more

Posts pagination

1 2 Next Posts»
WordPress Theme: Gridbox by ThemeZee.